Friday, July 21, 2017

Actavis’ Depression Drug Gains FDA Approval for New Dose – Analyst Blog

March 17, 2015 by  
Filed under Depression

Actavis (ACT) gained FDA approval for the lower dose of Viibryd (20 mg) for the treatment of adult patients suffering from major depressive disorder.

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!